Medical Tech Outlook Weekly Brief
Be first to read the latest tech news, Industry Leader's Insights, and CIO interviews of medium and large enterprises exclusively from Medical Tech Outlook
Control Bionics has introduced the latest addition to its Augmentative and Alternative Communication (AAC) device line, and it is the GridPad Trilogy communication solution. 
Rob Won, CEO
FREMONT, CA: Control Bionics has introduced the latest addition to its Augmentative and Alternative Communication (AAC) device line, called the GridPad Trilogy communication solution. The new neuro-based voice output communication aid is designed to help people who have to live with a range of conditions, consisting of ALS, Spinal Muscular Atrophy (SMA), Cerebral Palsy, and Spinal Cord Injury.
It also provides touch control, eye control, and NeuroNode 3.0 control in the same system. Furthermore, the GridPad Trilogy is a unique 3-in-1 AAC device that advances and grows with clients and their capabilities. It also allows faster communication, at rates up to 133 percent in comparison with other systems. Since it offers numerous access methods in the same system, the traditional insurance barriers that have limited access to methods and features are improved to be available for the people who need it most.
According to Rob Wong, CEO, Control Bionics, "Our mission is to develop accessible, leading-edge AAC devices that can help those living with paralysis and loss of speech gain more control over their world. Our latest solution, the GridPad Trilogy, is the result of strategic partnerships with some of the best minds in the industry, resulting in a technology that provides unparalleled benefits for our clients."
The GridPad Trilogy also has Control Bionics wireless wearable NeuroNode 3.0 technology, united with the powerful Smartbox Grid Pad 12 computer system and IntelliGaze v5 eye gaze device from Alea Technologies. Such a highly advanced combination of technologies allows faster-typing speed, reduced user fatigue, and more control. It also provides a 12-hour battery life, and it is the most extended battery life accessible on the market, thus increasing its reliability and flexibility.
James Schorey, Chief Technology Officer, Control Bionics, stated, "The new GridPad Trilogy will be an integral part of our product line, further enhancing our augmentative communication device offering.While our current Trilogy solution will continue to offer clients portability and speed, the new GridPad Trilogy is a more robust solution with unmatched battery life, sound quality and durability, rounding out our line to appeal to all needs."
Read Also
